 Q BioMed Inc OTCQB:QBIO has unveiled its largest single investment so far, with Aedesius Holdings Ltd AedesiusOne, a privately held global disruption aggregator, investing up to 30 million in the company via a securities agreement. The biotech accelerator noted that AedesiusOne is run by Geoffrey Fatzinger, Q BioMeds global head of regulatory affairs. 